| 查看: 704 | 回复: 0 | ||
[求助]
求助翻译 关于HIF和shRNA
|
|
求助翻译： 菜鸟一个，这段有点搞不懂作者的意图是什么。。。 To investigate the role of each of the HIF-a subunits in human HSPCs, we constructed bicistronic lentiviral vectors carrying two distinct promoters, EF1a and H1, driving green fluorescent pro- tein (GFP) (reporter) and a small hairpin RNA (shRNA) against the HIF-1a (sequence published in Rezvani et al., 2007) or HIF-2a subunit, respectively (Figure S1B). To confirm the specificity and efficiency of these vectors, CD34+ cells were transduced (45%–80% transduction efficiency), FACS-sorted 4 days post- transduction, and cultured for an additional 4 days prior to our assessment of mRNA levels. A significant reduction in mRNA levels was observed for both HIF-1a and HIF-2a vectors relative to controls, with a decrease of 88% and 78%, respectively (Fig- ure 1B). The KD was also confirmed at the protein level in CD34+ cells (Figure 1C) and in 293T cells (Figure S1C). The shHIF1a used in this study has been previously validated elsewhere (Rezvani et al., 2007). However, to confirm the specificity and exclude off-target effects of the shRNA for HIF-2a, we tested a second shHIF2a (shHIF2a.2) (Figure S1D). Using this second vector, we confirmed an efficient KD at the protein level, as well as similar defects in vivo compared to the first shRNA used (shHIF2a.1) (Figure S1E). We then used the construct that gave us the best silencing activity (shHIF2a.1) for the rest of this study. 还有构建的shRNA作用是不是就是表达HIF1a和HIF2a？ 下游靶基因的表达减少是否意味着HIF1a和HIF2a的表达减少？ |
回复此楼» 猜你喜欢
面上项目申报
已经有3人回复
-
有时候真觉得大城市人没有县城人甚至个体户幸福
已经有5人回复
-
酰胺脱乙酰基
已经有9人回复
-
CSC & MSCA 博洛尼亚大学能源材料课题组博士/博士后招生｜MSCA经费充足、排名优
已经有5人回复
-
有70后还继续奋斗在职场上的吗？
已经有6人回复
-
博士延得我，科研能力直往上蹿
已经有7人回复
-
退学或坚持读
已经有27人回复
-
面上基金申报没有其他的参与者成吗
已经有5人回复
-
遇见不省心的家人很难过
已经有22人回复